Press release
Lupus Market Demand Expected to Rise, Projected to Reach USD 6.09 Billion by 2030
The ๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ was valued at USD 2.68 billion in 2023 and is projected to expand to USD 6.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.41% during the forecast period.๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The global lupus market is experiencing significant growth due to the rising incidence of lupus, a chronic autoimmune disease that causes widespread inflammation. The disease affects various organs, including the skin, joints, kidneys, and heart, and can be life-threatening if untreated. The market is propelled by ongoing advancements in treatments for systemic lupus erythematous (SLE), a severe form of lupus. As research into effective therapies continues, the market for lupus treatments is expected to expand rapidly, driven by a higher demand for innovative drugs and therapies aimed at managing and treating the disease.
๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ฌ ๐๐ฎ๐ฌ๐ญ ๐ ๐๐ฅ๐ข๐๐ค ๐๐ฐ๐๐ฒ! https://www.maximizemarketresearch.com/request-sample/65753/
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ:
The growing prevalence of lupus worldwide is one of the primary factors fueling market growth. With approximately 5 million people affected globally and a significant proportion suffering from systemic lupus erythematous, the demand for effective treatments is increasing. The advancements in research and development, along with the approval of new biologics and other therapies, are also contributing to market growth. Furthermore, the growing awareness about lupus and the push for better healthcare options are likely to drive further expansion of the market.
๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The lupus market is seeing a shift towards biologics, which are emerging as the preferred treatment due to their improved efficacy and fewer side effects compared to traditional medications like corticosteroids and immunosuppressants. The approval of new biologics, such as Benlysta and Rituximab, is expected to continue this trend, making biologic therapies a dominant force in the market. Additionally, personalized medicine and targeted treatments are gaining traction, allowing for more effective management of lupus symptoms and reducing the risk of flare-ups.
๐๐๐๐ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง? ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ + ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐๐ซ๐: https://www.maximizemarketresearch.com/inquiry-before-buying/65753/
๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ:
As lupus prevalence increases, there is a growing opportunity for new drug development, particularly for systemic lupus erythematous and lupus nephritis, a severe complication of lupus. The expanding market for biologics, alongside the demand for more specialized treatment options, offers a significant opportunity for companies to introduce innovative solutions. Furthermore, as awareness about lupus spreads, there are substantial opportunities in emerging markets where healthcare infrastructure is improving.
๐๐ก๐๐ญ ๐ข๐ฌ ๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ?
North America is poised to dominate the lupus market, primarily due to the high prevalence of the disease in the region, with the U.S. leading in the number of diagnosed cases. The region benefits from well-established healthcare infrastructure, increased availability of reimbursement, and access to innovative treatment options, especially biologics. This is expected to propel the market to a value of USD 89 billion by 2029, with a rapid growth rate of 50% over the forecast period. Additionally, government initiatives and rising demand for better treatment options are further contributing to the market's expansion in North America.
๐๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐๐๐ค ๐ข๐ง๐ฌ๐ข๐๐? ๐๐ซ๐๐ ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ:๏ปฟ https://www.maximizemarketresearch.com/request-sample/65753/ ๏ปฟ๏ปฟ
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ
by Technique
Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus
Drug-Induced Lupus Erythematosus
Neonatal Lupus
by Product
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Antimalarial Drugs
Corticosteroids
Immunosuppressants
Biologics
Others
by End User
Hospital & Clinics
Diagnostic Laboratories
Other
๐๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ ๐ฅ๐๐ซ๐ ๐๐ฌ๐ญ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ๐ฌ ๐จ๐ ๐๐ฎ๐ฉ๐ฎ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐
1. Aurinia Pharmaceuticals
2. Bristol-Myers Squibb
3. Cadila Healthcare
4. GlaxoSmithKline plc
5. Mylan N.V.
6. F. Hoffmann-La
7. Pfizer, Inc.
8. Sanofi
9. Lycera Corporation
10. Merck KGaA
11. Eli Lily
12. ImmuPharma LLC
13. Anthera Pharmaceuticals
14. Lycera
15. Sandoz International GmbH
๐๐๐ญ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐๐ง ๐๐ก๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ @ https://www.maximizemarketresearch.com/market-report/global-lupus-market/65753/ ๏ปฟ๏ปฟ๏ปฟ๏ปฟ
๐๐๐ฒ ๐๐๐๐๐ซ๐ข๐ง๐ ๐ฌ:
Past Lupus Market Size and Competitive Landscape
Lupus Market Size, Share, Size & Forecast by different segment
Lupus Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Lupus Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Lupus Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐จ๐ฎ๐ซ ๐ญ๐จ๐ฉ-๐ฉ๐๐ซ๐๐จ๐ซ๐ฆ๐ข๐ง๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐๐ญ๐๐ฌ๐ญ ๐ญ๐ซ๐๐ง๐๐ฌ:
โฆ Medical clothing Market https://www.maximizemarketresearch.com/market-report/medical-clothing-market/147694/
โฆ Live Streaming Market https://www.maximizemarketresearch.com/market-report/global-live-streaming-market/23862/
โฆ Indian Electric Vehicle Market https://www.maximizemarketresearch.com/market-report/indian-electric-vehicle-market/14886/
โฆ India Telecommunication Market https://www.maximizemarketresearch.com/market-report/india-telecommunication-market/45156/
โฆ Meltblown Fabrics Market https://www.maximizemarketresearch.com/market-report/meltblown-fabrics-market/194148/
โฆ Water Flosser Market https://www.maximizemarketresearch.com/market-report/water-flosser-market/201205/
โฆ Global Microcarrier Market https://www.maximizemarketresearch.com/market-report/global-microcarrier-market/34042/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โ +91 9607365656
๐ sales@maximizemarketresearch.com
๐ www.maximizemarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Market Demand Expected to Rise, Projected to Reach USD 6.09 Billion by 2030 here
News-ID: 3735947 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

GPS Tracking Device Market Surge Ahead at a CAGR of 13.1% from 2025 to 2032: Sma โฆ
GPS Tracking Device Market size was valued at USD 3.50 Billion in 2024 and the total GPS Tracking Device revenue is expected to grow at a CAGR of 13.1% from 2025 to 2032, reaching nearly USD 9.38 Billion.
GPS Tracking Device Market Overview:
The GPS tracking device market is entering a dynamic growth phase, propelled by mounting demand in logistics, automotive, personal safety, and healthcare industries. Innovations such as IoT integration, telematics,โฆ

Iron and Steel Slag Market to Grow at a CAGR of 1.5% in the Forecast Period of 2 โฆ
The Iron and Steel Slag Market size was valued at USD 25.81 Billion in 2024 and the total Iron and Steel Slag revenue is expected to grow at a CAGR of 1.5% from 2025 to 2032, reaching nearly USD 29.08 Billion.
Iron and Steel Slag Market Overview:
Iron and steel slag, a byproduct of metal smelting, is emerging as a linchpin in modern industrial ecosystems. Far from being waste, this versatile materialโฆ

Shooting Ranges Market Expected To Hit USD 2.57 Bn by 2032, with a CAGR of 7.85% โฆ
The Shooting Ranges Market size was valued at USD 1.40 Billion in 2024 and the total Shooting Ranges revenue is expected to grow at a CAGR of 7.85% from 2025 to 2032, reaching nearly USD 2.57 Billion.
Shooting Ranges Market Overview:
Shooting ranges serve as specialized facilities-both indoor and outdoor-where firearms and archery training, recreational shooting, and competitive events take place in controlled, safe environments. These venues support a wide spectrum ofโฆ

Fuel Cell UAV Market Taking Flight at Robust Growth Pace: A Clean-Energy Drone R โฆ
The Fuel Cell UAV Market size was valued at USD 1661.38 Million in 2024 and the total Fuel Cell UAV revenue is expected to grow at a CAGR of 13.95% from 2025 to 2032, reaching nearly USD 4722.62 Million.
Fuel Cell UAV Market Overview:
Fuel-cell-powered unmanned aerial vehicles (UAVs) are swiftly redefining the drone landscape with their promise of prolonged flight times and greener operations. Leading aerospace innovators and emerging startups alikeโฆ
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Risingโฆ
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C โฆ
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and softโฆ
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additionalโฆ
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth ofโฆ
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present โLupus Erythematosus-API Insights, 2017โ
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentageโฆ
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% โฆ
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled โPharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,โ to its expanding repository of research reports. The marketโฆ